A Remote Patient Monitoring program utilizing Smart Meter’s Cellular-Connected RPM devices delivers measurable clinical outcomes and sets the stage for expanded collaboration to serve FQHCs across the United States.

Smart Meter, the number one supplier of technology and services for remote patient monitoring, and digiiMED, a leader in technology-enabled clinical services for value-based care, today announced the results of a high-impact hypertension management pilot conducted across three Federally Qualified Health Centers (FQHCs) in Puerto Rico. digiiMED also announced plans to expand their offering into the continental United States, bringing their RPM and clinical services model, powered by Smart Meter cellular devices, to FQHCs and underserved patient populations nationwide.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260303767200/en/

Funded by the Puerto Rico Primary Care Association (PRPCA), the program was implemented between May and September 2025. digiiMED was awarded the initiative through a competitive RFP process, and provided bilingual, culturally-competent clinical care management, project management, data analysis, and Smart Meter’s iBloodPressure® cellular-enabled monitoring devices.

The pilot demonstrates the measurable impact of combining cellular-connected RPM technology with proactive clinical engagement to improve chronic disease outcomes in underserved populations and establishes a blueprint for broader U.S. deployment.

Strong Enrollment, Engagement, and Data Capture

The program enrolled 360 patients with uncontrolled hypertension, identified based on their most recently documented blood pressure readings. The average age of patients in the program was 66, reflecting a high-risk population with significant need for ongoing monitoring and intervention.

Enrollment was completed by July 2025, and patient engagement remained strong throughout the pilot:

• 333 patients actively transmitted readings
• Patients averaged 14 readings per patient per month
• More than 23,000 blood pressure readings were collected
• Data seamlessly integrated into patient charts within their Electronic Health Record (EHR) platform following RPM program activation

This consistent flow of actionable data enabled care teams to intervene earlier, adjust treatment plans, and maintain continuous visibility into patient status outside the clinic.

Clinically Meaningful Outcomes Achieved

A retrospective analysis of 179 patients meeting study criteria revealed significant improvements in blood pressure control and overall hypertension management:

• 30% achieved clinically meaningful improvement
• 54% of patients with uncontrolled hypertension reached blood pressure control by the end of the program

The program’s primary objective was to support blood pressure control aligned with HRSA Uniform Data System (UDS) Blood Pressure Control metrics, a key quality benchmark for FQHCs. Results underscore RPM’s effectiveness as a scalable solution for improving chronic disease outcomes while supporting regulatory reporting and value-based care performance.

“This program validates what is possible when reliable, always-connected technology is paired with proactive, clinical engagement,” said Casey Pittock, CEO of Smart Meter. “We are excited to support digiiMED’s expansion into the U.S. market and to bring this proven model to FQHCs nationwide that are seeking scalable ways to improve hypertension control, meet quality metrics, and enhance patient access to care.”

Expansion into the U.S. FQHC Market

Building on the success of the Puerto Rico pilot, digiiMED is formalizing a strategic expansion into the broader U.S. market, with an initial focus on FQHCs and other safety-net providers managing high rates of uncontrolled chronic disease.

digiiMED plans to introduce its bilingual, culturally-competent, clinically-integrated RPM services model to U.S.-based health centers, leveraging Smart Meter’s fully cellular device ecosystem and established national distribution footprint.

“The results in Puerto Rico demonstrate both clinical impact and operational scalability,” said José Alvarez, CEO of digiiMED. “As we expand into the United States, our goal is to help more FQHCs and primary care organizations improve outcomes for high-risk populations through a seamless combination of connected devices, bilingual clinical support, and actionable data.”

A Scalable Model for Value-Based Care

The pilot reinforces remote patient monitoring as a powerful tool for FQHCs and primary care organizations seeking to improve quality scores, increase patient engagement, and succeed under value-based reimbursement models.

With proven results, strong patient adherence, and seamless EHR integration, the Smart Meter–digiiMED model offers a scalable pathway to better chronic disease management across diverse and underserved populations throughout the United States.

About Smart Meter

Since 2016, customers have hired Smart Meter to help solve one of healthcare’s most critical challenges: remotely capturing and delivering accurate patient vitals securely and reliably every time. Today, Smart Meter is the number one trusted supplier of cellular-enabled remote patient monitoring solutions, delivering reliable, real-time patient data to healthcare providers, payers, and technology partners. With millions of vitals transmitted via its exclusive private data network for RPM, Smart Meter empowers organizations to securely improve patient outcomes, reduce hospitalizations, and optimize reimbursement. For more information, visit SmartMeterRPM.com. Attending HIMSS in Las Vegas? Stop by the Smart Meter booth (5244) to learn more!

About digiiMED

digiiMED LLC is a digital health services and consulting company focused on improving care for patients with chronic conditions. Through the use of digital devices, data-driven information systems, and dedicated clinical personnel, digiiMED ensures continuity of care and enables early detection of health risks. digiiMED empowers healthcare professionals with timely biometric and qualitative data to support informed clinical decision-making, while equipping patients with education, resources, and improved access to clinical services. digiiMED’s model promotes timely intervention, reduces the need for high-cost acute care, and fosters a culture centered on prevention. By aligning technology, clinical oversight, and patient engagement, digiiMED strives to deliver better health outcomes and positively impact the quality of life of Spanish-speaking patient populations across the United States and its territories. For more information, visit digiiMED.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260303767200/en/